1. Home
  2. AHT vs NERV Comparison

AHT vs NERV Comparison

Compare AHT & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AHT

Ashford Hospitality Trust Inc

HOLD

Current Price

$4.33

Market Cap

26.2M

Sector

Real Estate

ML Signal

HOLD

Logo Minerva Neurosciences Inc

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$4.16

Market Cap

29.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AHT
NERV
Founded
2003
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.2M
29.2M
IPO Year
2003
2014

Fundamental Metrics

Financial Performance
Metric
AHT
NERV
Price
$4.33
$4.16
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
454.2K
41.8K
Earning Date
11-04-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,119,102,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.90
$1.15
52 Week High
$10.35
$12.46

Technical Indicators

Market Signals
Indicator
AHT
NERV
Relative Strength Index (RSI) 58.85 54.89
Support Level $3.62 $3.90
Resistance Level $3.97 $4.20
Average True Range (ATR) 0.42 0.29
MACD 0.08 0.02
Stochastic Oscillator 73.56 85.22

Price Performance

Historical Comparison
AHT
NERV

About AHT Ashford Hospitality Trust Inc

Ashford Hospitality Trust Inc. is a real estate investment trust that invests in full-service upscale and upper-upscale hotel properties in the U.S. The company owns and operates its assets through its operating partnership, Ashford Hospitality Limited Partnership. All of its hotels are located across the U.S. and operate under the Marriott, Hilton, Hyatt, Crowne Plaza, and Sheraton brands. Ashford's sole segment is Direct Hotel Investments, through which it owns hotels by acquisition or development. Ashford also provides real estate investment services, such as mezzanine financing, first mortgage financing, and sales-leaseback transactions. Its revenue streams include Room revenue, Food and beverage revenue, and Other revenue. Room revenue accounts for the majority of total revenue.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.

Share on Social Networks: